Leoni Mollie 4

What Happened

• Mollie Leoni, Chief Medical Officer at Kura Oncology (KURA), reported four sales on 2026-01-27 totaling 8,180 shares at $8.46 per share. The individual lots were 3,655, 2,233, 951 and 1,341 shares, with aggregate proceeds of roughly $69.2K. These were sell-to-cover transactions tied to vested RSUs rather than discretionary stock sales.

Key Details

• Transaction date: 2026-01-27; price: $8.46 per share (each lot).
• Shares sold: 8,180 total; approximate proceeds: $69,200.
• Per-lot breakdown: 3,655 ($~30.9K), 2,233 ($~18.9K), 951 ($~8.0K), 1,341 ($~11.3K).
• Footnotes indicate these were sell-to-cover for taxes on RSUs vesting on 1/2/25, 1/26/24, 2/16/23 and 1/26/22.
• Filing/reporting: Form 4 dated and filed 2026-01-27 (no late filing indicated in the provided data).
• Shares owned after the transactions: not specified in the provided excerpt of the filing.

Context

• Sell-to-cover transactions are routine tax-withholding actions when RSUs vest and do not necessarily signal the insider’s view on the company’s prospects. This was a sale (code S) to cover tax obligations (footnote F), not a purchase or option exercise.